Drug Shortage Report for APO-VENLAFAXINE XR

Last updated on 2019-12-23 History
Report ID 69460
Drug Identification Number 02331705
Brand name APO-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name APOTEX INC
Active Ingredient(s) VENLAFAXINE
Strength(s) 150.0MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100 BTL
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-12-10
Actual start date 2018-12-11
Estimated end date Unknown
Actual end date 2019-12-20
Shortage status Resolved
Updated date 2019-12-23
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-12-12 English Compare
v2 2018-12-12 French Compare
v3 2018-12-14 English Compare
v4 2018-12-14 French Compare
v5 2018-12-18 English Compare
v6 2018-12-18 French Compare
v7 2019-02-13 English Compare
v8 2019-02-13 French Compare
v9 2019-03-15 English Compare
v10 2019-03-15 French Compare
v11 2019-04-26 English Compare
v12 2019-04-26 French Compare
v13 2019-06-07 English Compare
v14 2019-06-07 French Compare
v15 2019-07-12 English Compare
v16 2019-07-12 French Compare
v17 2019-09-16 English Compare
v18 2019-09-16 French Compare
v19 2019-12-23 English Compare
v20 2019-12-23 French Compare